Does RALTEGRAVIR Cause Dyslipidaemia? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Dyslipidaemia have been filed in association with RALTEGRAVIR (ISENTRESS). This represents 0.5% of all adverse event reports for RALTEGRAVIR.
46
Reports of Dyslipidaemia with RALTEGRAVIR
0.5%
of all RALTEGRAVIR reports
1
Deaths
18
Hospitalizations
How Dangerous Is Dyslipidaemia From RALTEGRAVIR?
Of the 46 reports, 1 (2.2%) resulted in death, 18 (39.1%) required hospitalization, and 3 (6.5%) were considered life-threatening.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RALTEGRAVIR. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does RALTEGRAVIR Cause?
Foetal exposure during pregnancy (1,033)
Maternal exposure during pregnancy (726)
Exposure during pregnancy (700)
Drug interaction (552)
Virologic failure (517)
Depression (482)
Death (431)
Pathogen resistance (425)
Drug resistance (388)
No adverse event (339)
What Other Drugs Cause Dyslipidaemia?
OLANZAPINE (230)
ROSUVASTATIN (206)
ARIPIPRAZOLE (185)
METHOTREXATE (175)
QUETIAPINE (161)
ATORVASTATIN (155)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
Which RALTEGRAVIR Alternatives Have Lower Dyslipidaemia Risk?
RALTEGRAVIR vs RALTITREXED
RALTEGRAVIR vs RAMELTEON
RALTEGRAVIR vs RAMIPRIL
RALTEGRAVIR vs RAMUCIRUMAB
RALTEGRAVIR vs RANEXA